Peiying Yang

Chang Gung University

Papers

1

Total Citations

5

H-Index

1

About

Peiying Yang is a prominent medical physicist whose research focuses on optimizing radiation therapy techniques to improve treatment outcomes and minimize long-term risks for cancer patients. Her key research areas include stereotactic body radiotherapy (SBRT), secondary cancer risk assessment, and advanced treatment planning systems. Yang's most notable contribution is her pioneering work on radiation-induced secondary cancer risk in lung cancer patients undergoing SBRT using the CyberKnife M6 system with a lung-optimized treatment (LOT) module. Her landmark 2020 study, which has garnered 5 citations, provided critical insights into lifetime secondary cancer risk assessment, demonstrating how advanced delivery systems can potentially reduce long-term complications while maintaining treatment efficacy. This work has significant implications for clinical decision-making in lung cancer management. Yang's research bridges the gap between technological innovation and patient safety, helping to establish safer protocols for modern radiotherapy. Her contributions are particularly valuable for researchers and clinicians seeking to balance aggressive tumor control with quality-of-life considerations in cancer survivors.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment
5 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Chang Gung University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago